Abstract
Invasion and metastasis of cancer cells involve a complex sequence of events that has been summarized by the use of the term invasion cascade. This concept lists a sequential order of phenomena involved in the complex pathway that cancer cells undertake to invade host tissue and then form metastases. The pathway probably starts with cancer cells leaving a primary lesion by individualization, i.e., being released from a controlling cellular environment. Individualized cancer cells can, due to still unknown mechanisms, acquire a motile phenotype that allows them to migrate through tissues. Morphologically, migrating cancer cells resemble locomoting neutrophils, i.e., being polarized with a leading front and rear end and equipped with a contractile cytoskeleton. Polarized tumor cells may react to chemokinetic and chemotactic stimuli. Migrating tumor cells undergo a continuous shape change and can transverse narrow intercellular spaces. On the other hand, they can acquire a secretory phenotype for diverse species of histolytic enzymes that degrade the extracellular matrix, specifically matrix metalloproteinases. By these mechanisms, cancer cells can invade lymph vessels and blood vessels to be transported to remote regions, where regrowth to metastases can ensue.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Aishima S, Taguchi K, Terashi T, Matsuura S, Shirmada M, Tsuneyoshi M (2003) Tenascin expression at the invasive front is associated with poor prognosis in intrahepatic cholangiocarcinoma. Mod Pathol 16:1019–1027
Andl CD (2010) The misregulation of cell adhesion components during tumorigenesis: overview and commentary. J Oncol. doi:10.1155/2010/174715
Araki K, Shimura T, Suzuki H, Tsutsumi S, Wada W, Yajima T, Kobayahi T, Kubo N, Kuwano H (2011) E/N-cadherin switch mediates cancer progression via TGF-β -induced epithelial-to-mesenchymal transition in extrahepatic cholangiocarcinoma. Br J Cancer 105:1885–1893
Ayaki M, Komatsu K, Mukai M, Murata K, Kameyama M, Ishiguro S, Miyoshi J, Tatsuta M, Nakamura H (2001) Reduced expression of focal adhesion kinase in liver metastases compared with matched primary human colorectal adenocarcinomas. Clin Cancer Res 7:3106–3112
Baek S, Lee YW, Yoon S, Baek SY, Kim BS, Oh SO (2010) CDH3/P-cadherin regulates migration of HuCCT1 cholangiocarcinoma cells. Anat Cell Biol 43:110–117
Bai XM, Zhang W, Liu NB, Jiang H, Lou KX, Peng T, Ma J, Zhang L, Zhang H, Leng J (2009) Focal adhesion kinase: important to prostaglandin E2-mediated adhesion, migration and invasion in hepatocellular carcinoma cells. Oncol Rep 21:129–136
Bao X, Fukuda M (2010) A tumor suppressor function of laminin-binding alpha-dystroglycan. Methods Enzymol 479:387–396
Batmunkh E, Tatrai P, Szabo E, Lodi C, Holczbauer A, Paska C, Kupcsulik P, Kiss A et al (2007) Comparison of the expression of agrin, a basement membrane heparan sulfate proteoglycan, in cholangiocarcinoma and hepatocellular carcinoma. Hum Pathol 38:1508–1515
Bauer R, Valletta D, Bauer K, Thasler WE, Hartmann A, Müller M, Reichert TE, Hellerbrand C (2014) Downregulation of P-cadherin expression in hepatocellular carcinoma induces tumorigenicity. Int J Clin Exp Pathol 7:6125–6132
Bear JE, Gertler FB (2009) Ena/VASP: towards resolving a pointed controversy at the barbed end. J Cell Sci 122:1947–1953
Behrens J, Weidner KM, Frixen UH, Schipper JH, Sachs M, Arakaki N, Daikuhara Y, Birchmeier W (1991) The role of E-cadherin and scatter factor in tumor invasion and cell motility. EXS 59:109–126
Belkin AM, Stepp MA (2000) Integrins as receptors for laminins. Microsc Res Tech 51:280–301
Benedicto I, Molina-Jimenez F, Barreiro O, Maldonado-Rodriguez A, Prieto J, Moreno-Otero R, Aldabe R, Lopez-Cabrera M et al (2008) Hepatitis C virus envelope components alter localization of hepatocyte tight junction-associated proteins and promote occludin retention in the endoplasmic reticulum. Hepatology 48:1044–1053
Bergamini C, Sgarra C, Trerotoli P, Lupo L, Azzariti A, Antonaci S, Giannelli G (2007) Laminin-5 stimulates hepatocellular growth through the different function of alpha6beta4 and alpha3beta1 integrins. Hepatology 46:1801–1809
Bewley MC, Tash BR, Tian F, Flanagan JM (2013) A complex affair. Attraction and repulsion make occludin and ZO-1 function! Tissue Barriers 1:e23496
Bliss KT, Chu M, Jones-Weinert CM, Gregorio CC (2013) Investigating lasp-2 in cell adhesion: new binding partners and roles in motility. Mol Biol Cell 24:995–1006
Boissan M, De Wever O, Lizarraga F, Wendum D, Poincloux R, Chignard N, Desbois-Mouthon C et al (2010) Implication of metastasis suppressor NM23-H1 in maintaining adherens junctions and limiting the invasive potential of human cancer cells. Cancer Res 70:7710–7722
Bouchagier KA, Assimakopoulos SF, Karavias DD, Maroulis I, Tzelepi V, Kalofonos H, Karavias DD, Kardamakis D et al (2014) Expression of claudins-1,-4,-5,-7 and occludin in hepatocellular carcinoma and their relation with classic clinicopathological features and patients’ survival. In Vivo 28:315–326
Brahme NN, Harburger DS, Kemp-O’Brien K, Stewart R, Raghavan S, Parsons M et al (2013) Kindlin binds migfilin tandem LIM domains and regulates migfilin focal adhesion localization and recruitment dynamics. J Biol Chem 288:35604–35616
Brokalaki EI, Weber F, Sotiropoulos GC, Daoudaki M, Cicinnati VR, Beckebaum S (2012) Claudin-7 expression in hepatocellular carcinoma. Transplant Proc 44:2737–2740
Cai L, Han J, Zhuo X, Xiong Y, Dong J, Li X (2009) Overexpression and significance of focal adhesion kinase in hepatocellular carcinoma and its relationship with HBV infection. Med Oncol 26:409–414
Calderwood DA, Huttenlocher A, Kiosses WB, Rose DM, Woodside DG, Schwartz MA, Ginsberg MH (2001) Increased filamin binding to beta-integrin cytoplasmic domain inhibits cell migration. Nat Cell Biol 3:1060–1068
Canel M, Serrels A, Frame MC, Brunton VG (2013) E-cadherin-integrin crosstalk in cancer invasion and metastasis. J Cell Sci 126:1–9
Cao et al. 2007. http://www.ncbi.nlm.nih.gov/pubmed/17880531
Cao X, Zhang L, Shi Y, Sun Y, Dai S, Guo C, Zhu F, Wang Q, Wang J, Wang X et al (2013) Human tumor necrosis factor (TNF)-alpha-induced protein 8-like 2 suppresses hepatocellular carcinoma metastasis through inhibiting Rac1. Mol Cancer 12:149
Castronovo V (1993) Laminin receptors and laminin-binding proteins during tumor invasion and metastasis. Invasion Metastasis 13:1–30
Chakraborty et al. 2015. http://www.ncbi.nlm.nih.gov/pubmed/25630468
Chan et al. 2011. http://www.ncbi.nlm.nih.gov/pubmed/21347395
Charni et al. 2009. http://www.ncbi.nlm.nih.gov/pubmed/19632304
Chen PW, Kroog GS (2010) Leupaxin is similar to paxillin in focal adhesion targeting and tyrosine phosphorylation but has distinct roles in cell adhesion and spreading. Cell Adh Migr 4:527–540
Chen JS, Huang XH, Wang Q, Chen XL, Fu XH, Tan HX, Zhang LJ, Li W, Bi J (2010) FAK is involved in invasion and metastasis of hepatocellular carcinoma. Clin Exp Metastasis 27:71–82
Chen YL, Wang TH, Hsu HC, Yuan RH, Jeng YM (2013) Overexpression of CTHRC1 in hepatocellular carcinoma promotes tumor invasion and predicts poor prognosis. PLoS One 8:e70324
Chen J, Zhao J, Ma R, Lin H, Liang X, Cai X (2014a) Prognostic significance of E-cadherin expression in hepatocellular carcinoma: a meta-analysis. PLoS One 9:e103952
Chen RX, Song HY, Dong YY, Hu C, Zheng QD, Xue TC, Liu XH, Zhang Y, Chen J, Ren ZG, Liu YK, Cui JF (2014b) Dynamic expression patterns of differential proteins during early invasion of hepatocellular carcinoma. PLoS One 9:e88543
Cheng ZX, Huang XH, Wang Q, Chen JS, Zhang LJ, Chen XL (2012) Clinical significance of decreased nidogen-2 expression in the tumor tissue and serum of patients with hepatocellular carcinoma. J Surg Oncol 105:71–80
Cheng N, Li Y, Han ZG (2013) Argonaute2 promotes tumor metastasis by way of up-regulating focal adhesion kinase expression in hepatocellular carcinoma. Hepatology 57:1906–1918
Cheng CC, Lai YC, Lai YS, Hsu YH, Chao WT, Sia KC, Tseng YH, Liu YH (2015) Transient knockdown-mediated deficiency in plectin alters hepatocellular motility in association with activated FAK and RAC-1-GTPase. Cancer Cell Int 15:29
Chiquet-Ehrismann R (1993) Tenascin and other adhesion-modulating proteins in cancer. Semin Cancer Biol 4:301–310
Cho SB, Lee KH, Lee JH, Park SY, Lee WS, Park CH, Kim HS, Choi SK, Rew JS (2008) Expression of E-and N-cadherin and clinicopathology in hepatocellular carcinoma. Pathol Int 58:635–642
Chu PY, Huang LY, Hsu CH, Liang CC, Guan JL, Hung TH, Shen TL (2009) Tyrosine phosphorylation of growth factor receptor-bound protein-7 by focal adhesion kinase in the regulation of cell migration, proliferation, and tumorigenesis. J Biol Chem 284:20215–20226
Cichon C, Sabharwal H, Rüter C, Schmidt MA (2014) MicroRNAs regulate tight junction proteins and modulate epithelial/endothelial barrier functions. Tissue Barriers 2:e944446
Citi S, Pulimeno P, Paschoud S (2012) Cingulin, paracingulin, and PLEKHA7: signaling and cytoskeletal adaptors at the apical junctional complex. Ann N Y Acad Sci 1257:125–132
Citi S, Guerrera D, Spadaro D, Shah J (2014) Epithelial junctions and Rho family GTPases: the zonular signalosome. Small GTPases 5:1–15
Cray LA, Guan JL (1999) Focal adhesion kinase in integrin-mediated signaling. Front Biosci 4:D102–D113
Dai Z, Zhou SL, Zhou ZJ, Bai DS, Xu XY, Fu XT, Chen Q, Zhao YM, Yu L, Yang GH, Wang Z, Wu WZ, Zhou J et al (2014) Capn4 contributes to tumour growth and metastasis of hepatocellular carcinoma by activation of the FAK-Src signalling pathways. J Pathol 234:316–328
Deb M, Sengupta D, Patra SK (2012) Integrin-epigenetics: a system with imperative impact on cancer. Cancer Metastasis Rev 31:221–234
Di Modugno F, Iapicca P, Boudreau A, Mottolese M, Terrenato I, Perracchio L, Carstens RP et al (2012) Splicing program of human MENA produces a previously undescribed isoform associated with invasive, mesenchymal-like breast tumors. Proc Natl Acad Sci U S A 109:19280–19285
Djaafri I, Khayati F, Menashi S, Tost J, Podgorniak MP, Sadoux A, Daunay A, Teixeira L, Soulier J, Idbaih A, Setterblad N et al (2014) A novel tumor suppressor function of Kindlin-3 in solid cancer. Oncotarget 5:8970–8985
Donato MF, Colombo M, Matarazzo M, Paronetto F (1989) Distribution of basement membrane components I human hepatocellular carcinoma. Cancer 63:272–279
Du GS, Wang JM, Lu JX, Li Q, Ma CQ, Du JT, Zou SQ (2009) Expression of P-aPKC-iota, E-cadherin, and beta-catenin related to invasion and metastasis in hepatocellular carcinoma. Ann Surg Oncol 16:1578–1586
Ebnet K (2013) JAM-A and aPKC. A close pair during cell-cell contact maturation and tight junction formation in epithelial cells. Tissue Barriers 1:e22993
Edwards S, Lalor P, Tuncer C, Adams DH (2006) Vitronectin in human hepatic tumours contributes to the recruitment of lymphocytes in an alpha v beta3-independent manner. Br J Cancer 95:1545–1554
Eleniste PP, Bruzzaniti A (2012) Focal adhesion kinases in adhesion structures and disease. J Signal Transduct 2012:296450
Endo K, Ueda K, Ueyama J, Ohta T, Terada T (2000) Immunoreactive E-cadherin, alpha-catenin, beta-catenin, and gamma-catenin proteins in hepatocellular carcinoma: relationships with tumor grade, clinicopathologic parameters, and patients’ survival. Hum Pathol 31:558–565
Enjoji M, Sakai H, Nakashima M, Nawata H (1998) Integrins: utility as cell type- and stage-specific markers for hepatocellular carcinoma and cholangiocarcinoma. In Vitro Cell Dev Biol Anim 34:25–27
Faouzi S, Le Bail B, Neaud V, Boussarie L, Saric J, Bioulac-Sage P, Balabaud C, Rosenbaum J (1999) Myofibroblasts are responsible for collagen synthesis in the stroma of human hepatocellular carcinoma: an in vivo in vitro study. J Hepatol 30:275–284
Feng XX, Liu M, Yan W, Zhou ZZ, Xia YJ, Tu W, Li PY, Tian DA (2013) β3 integrin promotes TGF-β1/H2O2/HOCl-mediated induction of metastatic phenotype of hepatocellular carcinoma cells by enhancing TGF-β1 signaling. PLoS One 8:e79857
Fletcher NF, Sutaria R, Jo J, Barnes A, Blahova M, Meredith LW, Cosset FL, Curbishley SM, Adams DH, Bertoletti A et al (2014) Activated macrophages promote hepatitis C virus entry in a tumor necrosis factor-dependent manner. Hepatology 59:1320–1330
Fonar Y, Frank D (2011) FAK and WNT signaling: the meeting of two pathways in cancer and development. Anticancer Agents Med Chem 11:600–606
Fransvea E, Mazzocca A, Antonaci S, Giannelli G (2009) Targeting transforming growth factor (TGF)-betaRI inhibits activation of beta1 integrin and blocks vascular invasion in hepatocellular carcinoma. Hepatology 49:839–850
Frantz C, Stewart KM, Weaver VM (2010) The extracellular matrix at a glance. J Cell Sci 123:4195–4200
Friedl P, Alexander S (2011) Cancer invasion and the microenvironment: plasticity and reciprocity. Cell 147:992–1009
Frixen UH, Behrens J, Sachs M, Eberle G, Voss B, Warda A, Löchner D, Birchmeier W (1991) E-cadherin-mediated cell-cell adhesion prevents invasiveness of human carcinoma cells. J Cell Biol 113:173–185
Fujii T, Koshikawa K, Nomoto S, Okochi O, Kaneko T, Inoue S, Yatabe Y, Takeda S, Nakao A (2004) Focal adhesion kinase is overexpressed in hepatocellular and can be served as an independent prognostic factor. J Hepatol 41:104–111
Ganguly KK, Pal S, Moulik S, Chatterjee A (2013) Integrins and metastasis. Cell Adhes Migr 7:251–261
Gao N, He H, Xiao L, Gao X, Shi H, Wu Q, Xu N, Lei Y, Song X, Hou Y (2015) The effects of focal adhesion kinase on the mobility, proliferation and apoptosis of Caco2 and SMMC-7721 cells. Med Oncol 32:567
Garay E, Patino-Lopez G, Islas S, Alarcon L, Canche–Pool E, Valle-Rios R, Medina-Contreras O et al (2010) CRTAM: a molecule involved in epithelial cell adhesion. J Cell Biochem 111:111–122
Ge YS, Liu D, Jia WD, Li JS, Ma JL, Yu JH, Xu GL (2015) Kindlin-2: a novel prognostic biomarker for patients with hepatocellular carcinoma. Pathol Res Pract 211:198–202
Giannelli G, Bergamini C, Fransvea E, Marinosci F, Quaranta V, Antonaci S (2001) Human hepatocellular carcinoma (HCC) cells require both alpha3beta1 integrin and matrix metalloproteinases activity for migration and invasion. Lab Invest 81:613–627
Giannelli G, Astigiano S, Antonaci S, Morini M, Barbieri O, Noonan DM, Albini A (2002) Role of the alpha3beta1 and alpha6beta4 integrins in tumor invasion. Clin Exp Metastasis 19:217–223
Giannelli et al. 2005. http://www.ncbi.nlm.nih.gov/pubmed/16285438
Gkretsi V, Bogdanos DP (2015) Experimental evidence of Migfilin as a new therapeutic target of hepatocellular carcinoma metastasis. Exp Cell Res. doi:10.1016/j.yexcr.2015.03.002
Golubovskaya VM, Cance WG (2007) Focal adhesion kinase and p53 signaling in cancer cells. Int Rev Cytol 263:103–153
Gonzalez-Mariscal L, Dominguez-Calderon A, Raya-Sandino A, Ortega-Olvera JM, Vargas-Sierra Q, Martinez-Revollar G (2014) Tight junctions and the regulation of gene expression. Semin Cell Dev Biol 36:213–223
Gotoh M, Sakamoto M, Kanetaka K, Chuuma M, Hirohashi S (2002) Overexpression of osteopontin in hepatocellular carcinoma. Pathol Int 52:19–24
Grosse B, Degrouard J, Jaillard D, Cassio D (2013) Build them up and break them down: tight junctions of cell lines expressing typical hepatocyte polarity with a varied repertoire of claudins. Tissue Barriers 1:e25210
Guillemot L, Guerrera D, Spadaro D, Tapla R, Jond L, Citi S (2014) MgcRacGAP interacts with cingulin and paracingulin to regulate Rac1 activation and development of the tight junction barrier during epithelial junction assembly. Mol Biol Cell 25:1995–2005
Gulubova MV (1997) Collagen type III and type IV detection in and around human hepatocellular carcinoma. Gen Diagn Pathol 142:155–163
Guo X, Xiong L, Zou L, Sun T, Zhang J, Li H, Peng R, Zhao J (2012) L1 cell adhesion molecule overexpression in hepatocellular carcinoma associates with advanced tumor progression and poor patient survival. Diagn Pathol 7:96
Gupton SL, Riquelme D, Hughes-Alford SK, Tadros J, Rudina SS, Hynes RO, Lauffenburger D et al (2012) Mena binds a5 integrin directly and modulates a5b1 function. J Cell Biol 198:657–676
Hall CL, Turley EA (1995) Hyaluronan: RHAMM mediated cell locomotion and signaling in tumorigenesis. J Neurooncol 26:221–229
Hall CL, Wang C, Lange LA, Turley EA (1994) Hyaluronan and the hyaluronan receptor RHAMM promote focal adhesion turnover and transient tyrosine kinase activity. J Cell Biol 126:575–588
Han NM, Fleming RY, Curley SA, Gallick GE (1997) Overexpression of ocal adhesion kinase (p125FAK) in human colorectal carcinoma liver metastases: independence from c-src or c-yes activation. Ann Surg Oncol 4:264–268
Han et al. 2014. http://www.ncbi.nlm.nih.gov/pubmed/24284889
Hao JL, Cozzi PJ, Khatri A, Power CA, Li Y (2010) CD147/EMMPRIN and CD44 are potential therapeutic targets for metastatic prostate cancer. Curr Cancer Drug Targets 10:287–306
Hashiguchi M, Ueno S, Sakoda M, Iino S, Hiwatashi K, Minami K, Ando K, Mataki Y et al (2013) Clinical implication of ZEB-1 and E-cadherin expression in hepatocellular carcinoma (HCC). BMC Cancer 13:572
Hauck CR, Hsia DA, Schlaepfer DD (2002) The focal adhesion kinase-a regulator of cell migration and invasion. IUBMB Life 53:115–119
Hayashi T (2010) Integrins modulate cellular fibrogenesis at multiple levels; regulation of TGF-β signaling. Endocr Metab Immune Disord Drug Targets 10:302–319
Hayashi et al. 2011. http://www.ncbi.nlm.nih.gov/pubmed/21323792
Hirose T, Izumi Y, Nagashima Y, Tamai-Nagai Y, Kurihara H, Sakai T, Suzuki Y, Yamanaka T, Suzuki A, Mizuno K et al (2002) Involvement of ASIP/PAR-3 in the promotion of epithelial tight junction formation. J Cell Sci 115:2485–2495
Hoffman et al. 2006. http://www.ncbi.nlm.nih.gov/pubmed/16505170
Hokaiwado N, Asamoto M, Futakuchi M, Ogawa K, Takahashi S, Shirai T (2007) Both early and late stages of hepatocarcinogenesis are enhanced in Cx32 dominant negative mutant transgenic rats with disrupted gap junctional intercellular communication. J Membr Biol 218:101–106
Hu YJ, Li HY, Qiu KJ, Li DC, Zhou JH, Hu YH, Zhang FM (2014) Downregulation of Notch1 inhibits the invasion of human hepatocellular carcinoma HepG2 and MHCC97H cells through the regulation of PTEN and FAK. Int J Mol Med 34:1081–1086
Huang X, Ji G, Wu Y, Wan B, Yu L (2008) LAMA4, highly expressed in human hepatocellular carcinoma from Chinese patients, is a novel marker of tumor invasion and metastasis. J Cancer Res Clin Oncol 134:705–714
Inayoshi J, Ichida T, Sugitani S, Tsuboi Y, Genda T, Honma N, Asakura H (2003) Gross appearance of hepatocellular carcinoma reflects E-cadherin expression and risk of early recurrence after surgical treatment. J Gastroenterol Hepatol 18:673–677
Inoue M, Ajioka Y, Wakai T, Takamura M, Korita P, Shirai Y, Hatakeyama K (2011) Liver-intestine cadherin in intraepithelial neoplasia of intrahepatic cholangiocarcinoma. Hepatogastroenterology 58:2045–2051
Inuzuka S, Ueno T, Torimura T, Tamaki S, Sakata R, Sata M, Yoshida H, Tanikawa K (1992) Vitronectin in liver disorders: biochemical and immunohistochemical studies. Hepatology 15:629–636
Isemura M, Yosizawa Z, Kojima N, Ichida F (1982) Fibronectin in human hepatocellular carcinoma. Tohoku J Exp Med 138:441–442
Itoh S, Maeda T, Shimada M, Aishima SI, Shirabe K, Tanaka S, Maehara Y (2004) Role of expression of focal adhesion kinase in progression of hepatocellular carcinoma. Clin Cancer Res 10:2812–2817
Jagirdar J, Ishak KG, Colombo M, Brambilla C, Paronetto F (1985) Fibronectin patterns in hepatocellular carcinoma and its clinical significance. Cancer 56:1643–1648
Jan YJ, Ko BS, Hsu C, Chang TC, Chen SC, Wang J, Liou JY (2009) Overexpressed focal adhesion kinase predicts a higher incidence of extrahepatic metastasis and worse survival in hepatocellular carcinoma. Hum Pathol 40:1384–1390
Jao TM, Tsai MH, Lio HY, Weng WT, Chen CC, Tzeng ST, Chang CY, Lai YC, Yen SJ, Yu SL, Yang YC (2014) Protocadherin 10 suppresses tumorigenesis and metastasis in colorectal cancer and its genetic loss predicts adverse prognosis. Int J Cancer 135:2593–2603
Jia YL, Shi L, Zhou JN, Fu CJ, Chen L, Yuan HF, Wang YF, Yan XL, Xu YC, Zeng Q, Yue W, Pei XT (2011) Epimorphin promotes human hepatocellular carcinoma invasion and metastasis through activation of focal adhesion kinase/extracellular signal-related kinase/matrix metalloproteinase-9 axis. Hepatology 54:1808–1818
Jin Y, Chen JN, Feng ZY, Zhang ZG, Fan WZ, Wang Y, Li JP (2014) OPN and αvβ3 expression are predictors of disease severity and worse prognosis in hepatocellular carcinoma. PLoS One 9:e87930
Jing Y, Jia D, Wong CM, Oi-Lin NI, Zhang Z, Liu L, Wang Q, Zhao F, Li J, Yao M et al (2014) SERPINA5 inhibits tumor cell migration by modulating the fibronectin-integrin b1 signaling pathway in hepatocellular carcinoma. Mol Oncol 8:366–377
Katabami K, Mizuno H, Sano R, Saito Y, Ogura M, Itoh S, Tsuji T (2005) Transforming growth factor-beta1 upregulates transcription of alpha3 integrin gene in hepatocellular carcinoma cells via Ets-transcription factor-binding motif in the promoter region. Clin Exp Metastasis 22:539–548
Katagiri YU, Sleeman J, Fujii H, Herrlich P, Hotta H, Tanaka K, Chikuma S, Yagita H et al (1999) CD44 variants but not CD44s cooperates with beta1-containing integrins to permit cells to bind to osteopontin independently of arginine-glycine-aspartic acid, thereby stimulating cell motility and chemotaxis. Cancer Res 59:219–226
Kiema T, Lad Y, Jiang P, Oxley CL, Baldassarre M, Wegener KL, Campbell ID, Ylänne J, Calderwood DA (2006) The molecular basis of filamin binding to integrins and competition with talin. Mol Cell 21:337–347
Kikkawa Y, Sanzen N, Fujiwara H, Sonnenberg A, Sekiguchi K (2000) Integrin binding specificity of laminin-10/11: laminin-10/11 are recognized by alpha 3 beta 1, alpha 6 beta 1 and alpha 6 beta 4 integrins. J Cell Sci 113:869–876
Kikkawa Y, Sudo R, Kon J, Mizuguchi T, Nomizu M, Hirata K, Mitaka T (2008) Laminin alpha 5 mediates ectopic adhesion of hepatocellular carcinoma hrough integrins and/or Lutheran/basal cell adhesion molecule. Exp Cell Res 314:2579–2590
Kojima T, Murata M, Go M, Spray DC, Sawada N (2007) Connexins induce and maintain tight junctions in epithelial cells. J Membr Biol 217:13–19
Konopka G, Tekiela J, Iverson M, Wells C, Duncan SA (2007) Junctional adhesion molecule-A is critical for the formation of pseudocanaliculi and modulates E-cadherin expression in hepatic cells. J Biol Chem 282:28137–28148
Kornberg LJ (1998) Focal adhesion kinase and its potential involvement in tumor invasion and metastasis. Head Neck 20:745–752
Koukoulis GK, Shen J, Virtanen I, Gould VE (1995) Immunolocalization of cellular fibronectins in the normal liver, cirrhosis, and hepatocellular carcinoma. Ultrastruct Pathol 19:37–43
Koval M (2013) Differential pathways of claudin oligomerization and integration into tight junctions. Tissue Barriers 1:e24518
Lai-Cheong JE, Ussar S, Arita K, Hart IR, McGrath JA (2008) Colocalization of kindlin-1, kindlin-2, and migfilin at keratinocyte focal adhesion and relevance to the pathophysiology of Kindler syndrome. J Invest Dermatol 128:2156–2165
Lark AL, Livasy CA, Calvo B, Caskey L, Moore DT, Yang X, Cance WG (2003) Overexpression of focal adhesion kinase in primary colorectal carcinomas and colorectal liver metastases: immunohistochemistry and real-time PCR analyses. Clin Cancer Res 9:215–222
Leber MF, Efferth T (2009) Molecular principles of cancer invasion and metastasis (review). Int J Oncol 34:881–895
Li P, Lin Y, Zhang Y, Zhu Z, Huo K (2013) SSX2IP promotes metastasis and chemotherapeutic resistance of hepatocellular carcinoma. J Transl Med 11:52
Li Z, Tang M, Ling B, Liu S, Zheng Y, Nie C, Yuan Z, Zhou L, Guo G, Tong A, Wie Y (2014) Increased expression of S100A6 promotes cell proliferation and migration in human hepatocellular carcinoma. J Mol Med (Berl) 92:291–303
Lian WX, Yin RH, Kong XZ, Zhang T, Huang XH, Zheng WW, Yang Y, Zhan YQ et al (2012) THAP11, a novel binding protein of PCBP1, negatively regulates CD44 alternative splicing and cell invasion in a human hepatoma cell line. FEBS Lett 586:1431–1438
Liang Q, Han Q, Huang W, Nan G, Xu BQ, Jiang JL, Chen ZN (2014) Hab18G/CD147 regulates vinculin-mediated focal adhesion and cytoskeleton organization in cultured human hepatocellular carcinoma cells. PLoS One 9:e102496
Liao Z, Kato H, Pandey M, Cantor JM, Ablooglu AJ, Ginsberg MH, Shattil SJ (2015) Interaction of kindlin-2 with integrin β3 promotes outside-in signaling responses by the αVβ3 vitronectin receptor. Blood 125:1995–2004
Lin L, McCroskery S, Ross JM, Chak Y, Neuhuber B, Daniels MP (2010) Induction of filopodia-like protrusions by transmembrane agrin: role of agrin glycosaminoglycan chains and Rho-family GTPases. Exp Cell Res 316:2260–2277
Lin L, Liang H, Wang Y, Yin X, Hu Y, Huang J, Ren T, Xu H, Zheng L, Chen X (2014a) microRNA-141 inhibits cell proliferation and invasion and promotes apoptosis by targeting hepatocyte nuclear factor-3β in hepatocellular carcinoma cells. BMC Cancer 14:879
Lin Y, Lin G, Fang W, Zhu H, Chu K (2014b) Increased expression of annexin A1 predicts poor prognosis in human hepatocellular carcinoma and enhances cell malignant phenotype. Med Oncol 31:327
Liu LX, Jiang HC, Liu ZH, Zhou J, Zhang WH, Zhu AL, Wang XQ, Wu M (2002) Integrin gene expression profiles of human hepatocellular carcinoma. World J Gastroenterol 8:631–637
Liu YH, Ho CC, Cheng CC, Pei RJ, Hsu YH, Yeh KT, Tsai MC, Lai YS (2007–2008) Pleomorphism of cancer cells with the expression of plectin and concept of filament bundles in human hepatocellular carcinoma. Res Coomun Mol Pathol Pharmacol 120–121:43–54
Liu YH, Cheng CC, Ho CC, Chao WT, Pei RJ, Hsu YH, Ho LC, Shiu BH, Lai YS (2011a) Plectin deficiency on cytoskeletal disorganization and transformation of human liver cells in vitro. Med Mol Morphol 44:21–26
Liu YH, Ho CC, Cheng CC, Chao WT, Pei RJ, Hsu YH, Lai YS (2011b) Cytokeratin 18-mediated disorganization of intermediate filaments is induced by degradation of plectin in human liver cells. Biochem Biophys Res Commun 407:575–580
Liu W, Tian F, Jiang P, Zhao X, Guo F, Li X, Wang S (2014) Aberrant expression of laminin g2 correlates with poor prognosis and promotes invasion in extrahepatic cholangiocarcinoma. J Surg Res 186:150–156
Liu YA, Liang BY, Guan Y, You J, Zhu L, Chen XP, Huang ZY (2015) Loss of N-cadherin is associated with loss of E-cadherin expression and poor outcome of liver resection in hepatocellular carcinoma. J Surg Res 194:167–176
Lopez D, Niu G, Huber P, Carter WB (2009) Tumor-induced upregulation of twist, snail, and slug represses the activity of the human VE-cadherin promoter. Arch Biochem Biophys 482:77–82
Luedde T (2010) MicroRNA-151 and its hosting gene FAK (focal adhesion kinase) regulate tumor cell migration and spreading of hepatocellular carcinoma. Hepatology 52:1164–1166
Ma XD, Ma X, Sui YF, Wang WL, Wang CM (2003) Signal transduction of gap junctional genes, connexin32, connexin43 in human hepatocarcinogenesis. World J Gastroenterol 9:946–950
Ma HX, Shu QH, Pan JJ, Liu D, Xu GL, Li JS, Ma JL, Jia WD, Yv JH, Ge YS (2015) Expression of Kindlin-1 in human hepatocellular carcinoma and its prognostic significance. Tumour Biol 36:4235–4241
Machesky L, Jurdic P, Hinz B (2008) Grab, stick, pull and digest: the functional diversity of actin-associated matrix-adhesion structures. EMBO Rep 9:139–143
Mao X, Chen D, Wu J, Li J, Zhou H, Wu Y, Duan X (2013) Differential expression of fascin, E-cadherin and vimentin: proteins associated with survival of cholangiocarcinoma patients. Am J Med Sci 346:261–268
Mareel M, Leroy A (2003) Clinical, cellular, and molecular aspects of cancer invasion. Physiol Rev 83:337–376
Mareel M, Oliveira MJ, Madani I (2009) Cancer invasion and metastasis: interacting ecosystems. Virchows Arch 454:599–622
Margadant C, Sonnenberg A (2010) Integrin-TGF-beta crosstalk in fibrosis, cancer and wound healing. EMBO Rep 11:97–105
Masumoto A, Arao S, Otsuki M (1999) Role of beta1 integrins in adhesion and invasion of hepatocellular carcinoma cells. Hepatology 29:68–74
Matsumoto A, Ono M, Fujimoto Y, Gallo RL, Bernfield M, Kohgo Y (1997) Reduced expression of syndecan-1 in human hepatocellular carcinoma with high metastatic potential. Int J Cancer 74:482–491
McCole DF (2013) Phosphatase regulation of intercellular junctions. Tissue Barriers 1:e26713
Minata M, Kudo M, Harada KH, Ikai I, Nishida N (2013) Expression of E-cadherin and vascular endothelial growth factor in noncancerous liver s associated with recurrence of hepatocellular carcinoma after curative resection. Oncology 84(Suppl 1):88–92
Miyao Y, Ozaki D, Nagao, Kondo Y (1999) Interstitial invasion of well-differentiated hepatocellular carcinoma and subsequent tumor growth. Pathol Int 49:208–213
Mizuno H, Ogura M, Saito Y, Sekine W, Sano G, Gotou T, Oku T, Itoh S, Katabami K, Tsuji T (2008) Changes in adhesive and migratory characteristics of hepatocellular carcinoma (HCC) cells induced by expression of alpha3beta1 integrin. Biochim Biophys Acta 1780:564–570
Mon NN, Ito S, Senga T, Hamaguchi M (2006) FAK signaling in neoplastic disorders: a linkage between inflammation and cancer. Ann N Y Acad Sci 1086:199–212
Mosnier JF, Kandel C, Cazals-Hatem D, Bou-Hanna C, Gournay J, Jarry A, Laboisse CL (2009) N-cadherin serves as diagnostic biomarker in intrahepatic and perihilar cholangiocarcinomas. Mod Pathol 22:182–190
Murata M, Kojima T, Yamamoto T, Go M, Takano K, Chiba H, Tokino T, Sawada N (2005) Tight junction protein MAGI-1 is up-regulated by transfection with connexin 32 in an immortalized mouse hepatic cell line: cDNA microarray analysis. Cell Tissue Res 319:341–347
Nakagawa H, Hikiba Y, Hirata Y, Font-Burgada J, Sakamoto K, Hayakawa Y, Taniguchi K, Umemura A, Kinoshita H et al (2014) Loss of liver E-cadherin induces sclerosing cholangitis and promotes carcinogenesis. Proc Natl Acad Sci U S A 111:1090–1095
Nakashima Y, Ono T, Yamanoi A, El-Assal ON, Kohno H, Nagasue N (2004) Expression of gap junction protein connexin32 in chronic hepatitis, liver cirrhosis, and hepatocellular carcinoma. J Gastroenterol 39:763–768
Nejjari M, Hafdi Z, Gouyesse G, Fiorentino M, Béatrix O, Dumortier J, Pourreyron C, Barozzi C, D’Errico A, Grigioni WF et al (2002) Expression, regulation, and function of alpha V integrins in hepatocellular carcinoma : an in vivo and in vitro study. Hepatology 36:418–426
Németh Z, Szasz AM, Somoracz A, Tatrai P, Németh J, Gyorffy H, Szijarto A, Kupcsulik P, Kiss A, Schaff Z (2009) Zonula occludens-1, occludin, and E-cadherin protein expression in biliary tract cancers. Pathol Oncol Res 15:533–539
Ng et al. 2013. http://www.ncbi.nlm.nih.gov/pubmed/23504997
Nikolopoulos SN, Turner CE (2000) Actopaxin, a new focal adhesion protein that binds paxillin LD motifs and actin and regulates cell adhesion. J Cell Biol 151:1435–1448
Nitta T, Mitsuhashi T, Hatanaka Y, Miyamoto M, Oba T, Tsuchikawa T, Suzuki Y, Hatanaka KC, Hirano S, Matsuno Y (2014) Prognosis significance of epithelial-mesenchymal transition-related markers in extrahepatic cholangiocarcinoma: comprehensive immunohistochemical study using a tissue microarray. Br J Cancer 111:1363–1372
Ogata R (1998) Type IV collagen and laminin enhance the motility, adhesion, and proliferation of hepatoma cells. Kurume Med J 45:11–20
Ohta R, Yamashita Y, Taketomi A, Kitagawa D, Kuroda Y, Itoh S, Aishima S, Maehara Y (2006) Reduced expression of focal adhesion kinase in intrahepatic cholangiocarcinoma is associated with poor tumor differentiation. Oncology 71:417–422
Orban E, Szabo E, Lotz G, Kupcsulik P, Paska C, Schaff Z, Kiss A (2008) Different expression of occludin and ZO-1 in primary and metastatic liver tumors. Pathol Oncol Res 14:299–306
Osada T, Sakamoto M, Ino Y, Iwamatsu A, Matsuno Y, Muto T, Hirohashi S (1996) E-cadherin is involved in the intrahepatic metastasis of hepatocellular carcinoma. Hepatology 24:1460–1467
Oyamada M, Krutovskikh VA, Mesnil M, Partensky C, Berger F, Yamasaki H (1990) Aberrant expression of gap junction gene in primary human hepatocellular carcinomas: increased expression of cardiac-type gap junction gene connexin 43. Mol Carcinog 3:273–278
Ozaki I, Yamamoto K, Mizuta T, Kajihara S, Fukushina N, Setoguchi Y, Morito F, Sakai T (1998) Differential expression of laminin receptors in human hepatocellular carcinoma. Gut 43:837–842
Ozaki I, Hamajima H, Matsuhashi S, Mizuta T (2011) Regulation of TGF-β1-induced pro-apoptotic signaling by growth factor receptors and extracellular matrix receptor integrins in the liver. Front Physiol 2:78
Palazzo AF, Gundersen GG (2002) Microtubule-actin cross-talk at focal adhesions. Sci STKE 2002(139):pe31
Paschoud S, Jond L, Guerrera D, Citi S (2014) PLEKHA7 modulates epithelial tight junction barrier function. Tissue Barriers 2:e28755
Qian et al. 2008. http://www.ncbi.nlm.nih.gov/pubmed/18847500
Qu H, Tu Y, Guan JL, Xiao G, Wu C (2014) Kindlin-2 tyrosine phosphorylation and interaction with Src serve as a regulatable switch in the integrin outside-in signaling circuit. J Biol Chem 289:31001–31013
Quail DF, Joyce JA (2013) Microenvironmental regulation of tumor progression and metastasis. Nat Med 19:1423–1437
Rao RK, Samak G (2013) Bile duct epithelial tight junctions and barrier function. Tissue Barriers 1:e25718
Reddig PJ, Juliano RL (2005) Clinging to life: cell to matrix adhesion and cell survival. Cancer Metastasis Rev 24:425–439
Riener MO, Vogetseder A, Pestalozzi BC, Clavien PA, Probst-hensch N, Kristiansen G, Jochum W (2010) Cell adhesion molecules P-cadherin and CD24 are markers for carcinoma and dysplasia in the biliary tract. Hum Pathol 41:1558–1565
Roskams T, De Vos R, David G, Van Damme B, Desmet V (1998) Heparan sulphate proteoglycan expression in human primary liver tumours. J Pathol 185:290–297
Rousseau A, Wilhelm LP, Tomasetto C, Alpy F (2014) The phosphoinositide-binding protein TRAF4 modulates tight junction stability and migration of cancer cells. Tissue Barriers 2:e975597
Sabit H, Tsuneyama K, Shimonishi T, Harada K, Cheng J, Ida H, Saku T, Saito K, Nakanuma Y (2001) Enhanced expression of basement-membrane-type heparan sulfate proteoglycan in tumor fibro-myxoid stroma of intrahepatic cholangiocarcinoma. Pathol Int 51:248–256
Samuel SK, Hurta RA, Spearman MA, Wright JA, Turley EA, Greenberg AH (1993) TGF-beta 1 stimulation of cell locomotion utilizes the hyaluronan receptor RHAMM and hyaluronan. J Cell Biol 123:749–758
Santamato A, Fransvea E, Dituri F, Caligiuri A, Quaranta M, Niimi T, Pinzani M, Antonaci S et al (2011) Hepatic stellate cells stimulate HCC cell migration via laminin-5 production. Clin Sci (Lond) 121:159–168
Schaller MD (2001) Paxillin: a focal adhesion-associated adaptor protein. Oncogene 20:6459–6472
Schlaepfer DD, Mitra SK, Ilic D (2004) Control of motile and invasive cell phenotypes by focal adhesion kinase. Biochim Biophys Acta 1692:77–102
Schmalhofer O, Brabletz S, Brabletz T (2009) E-cadherin, b-catenin, and ZEB1 in malignant progression of cancer. Cancer Metastasis Rev 28:151–166
Schmitt M, Horbach A, Kubitz R, Frilling A, Häussinger D (2004) Disruption of hepatocellular tight junctions by vascular endothelial growth factor (VEGF): a novel mechanism for tumor invasion. J Hepatol 41:274–283
Seo DD, Lee HC, Kim HJ, Min HJ, Kim KM, Lim YS, Chung YH, Lee YS, Suh DJ, Yu E, Chun SY (2008) Neural cadherin overexpression is a predictive marker for early postoperative recurrence in hepatocellular carcinoma patients. J Gastroenterol Hepatol 23:1112–1118
Settakorn J, Kaewpila N, Burns GF, Leong AS (2005) FAT, E-cadherin, beta catenin, HER2/neu, Ki67 immuno-expression, and histological grade in intrahepatic cholangiocarcinoma. J Clin Pathol 58:1249–1254
Shang N, Arteaga M, Zaidi A, Stauffer J, Cotler SJ, Zeleznik-Le NJ, Zhang J, Qiu W (2015) FAK is required for c-Met/β-catenin-driven hepatocarcinogenesis. Hepatology 61:214–226
She S, Xu B, He M, Lan X, Wang Q (2010) Nm23-H1 suppresses hepatocarcinoma cell adhesion and migration on fibronectin by modulating glycosylation of integrin beta1. J Exp Clin Cancer Res 29:93
Sheen IS, Jeng KS, Wang PC, Shih SC, Chang WH, Wang HY, Chen CC, Shyung LR (2004) Are gap junction gene connexins 26, 32 and 43 of prognostic values in hepatocellular carcinoma? A prospective study. World J Gastroenterol 10:2785–2790
Shen TL, Guan JL (2001) Differential regulation of cell migration and cell cycle progression by FAK complexes with Src, PI3K, Grb7 and Grb2 in focal contacts. FEBS Lett 499:176–181
Sobel ME (1993) Differential expression of the 67 kDa laminin receptor in cancer. Semin Cancer Biol 4:311–317
Soejima Y, Inoue M, Takahashi Y, Uozaki H, Sawabe M, Fukusato T (2014) Integrins αvβ6 and α3β1 are down-regulated in cholangiolocellular carcinoma but not cholangiocarcinoma. Hepatol Res 44:E320–E334
Stebbing et al. 2013. http://www.ncbi.nlm.nih.gov/pubmed/23318416
Suh et al. 2013. http://www.ncbi.nlm.nih.gov/pubmed/23160379
Sun et al. 2011. http://www.ncbi.nlm.nih.gov/pubmed/21533080
Sun C, Zargham R, Shao Q, Gui X, Marcus V, Lazaris A, Salman A, Metrakos P, Qu X, Gao Z (2014) Association of CD98, integrin β1, integrin β3 and Fak with the progression and liver metastases of colorectal cancer. Pathol Res Pract 210:668–674
Swift JG, Mukherjee M, Rowland R (1983) Intercellular junctions in hepatocellular carcinoma. J Submicrosc Cytol 15:799–810
Tabarin A, Bioulac-Sage P, Boussarie L, Balabaud C, de Mascarel A, Grimaud JA (1987) Hepatocellular carcinoma developed on noncirrhotic livers. Sinusoids in hepatocellular carcinoma. Arch Pathol Lab Med 111:174–180
Takahashi Y, Sawada G, Kurashiga J, Matsumura T, Uchi R, Ueo H, Ishibashi M, Takano Y, Akiyoshi S, Iwaya T et al (2013) Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells. Anticancer Res 33:1927–1943
Tameda M, Sugimoto K, Shiraki K, Yamamoto N, Okamoto R, Usui M, Ito M, Takei Y, Nobori T, Kojima T, Suzuki H et al (2014) Collagen triple helix repeat containing 1 is overexpressed in hepatocellular carcinoma and promotes cell proliferation and motility. Int J Oncol 45:541–548
Tanaka R, Seki Y, Saito Y, Kamiya S, Fujita M, Okutsu H, Iyoda T, Takai T, Owaki T, Yajima H, Taira J, Hayashi R et al (2014) Tenascin-C-derived peptide TNIIIA2 highly enhances cell survival and platelet-derived growth factor (PDGF)-dependent cell proliferation through potentiated and sustained activation of integrin α5β1. J Biol Chem 289:17699–17708
Tanimizu and Mitaka 2013. http://www.ncbi.nlm.nih.gov/pubmed/24665375
Tatrai P, Dudas J, Batmunkh E, Mathé M, Zalatnai A, Schaff Z, Ramadori G, Kovalszky I (2006) Agrin, a novel basement membrane component in human and rat liver, accumulates in cirrhosis and hepatocellular carcinoma. Lab Invest 86:1149–1160
Tatrai P, Egedi K, Somoracz A, van Kuppevelt TH, Ten Dam G, Lyon M, Deakin JA, Kiss A, Schaff Z, Kovalsky I (2010) Quantitative and qualitative alterations of heparan sulfate in fibrogenic liver diseases and hepatocellular cancer. J Histochem Cytochem 58:429–441
Terada T, Nakanuma Y (1994) Expression of tenascin, type IV collagen and laminin during human intrahepatic bile duct development and in intrahepatic cholangiocarcinoma. Histopathology 25:143–150
Tian B, Li Y, Ji XN, Chen J, Xue Q, Ye SL, Liu YK, Tang ZY (2005) Basement membrane proteins play an active role in the invasive process of human hepatocellular carcinoma cells with high metastasis potential. J Cancer Res Clin Oncol 131:80–86
Torimura T, Ueno T, Inuzuka S, Kin M, Ohira H, Kimura Y, Majima Y, Sata M, Abe H, Tanikawa K (1994) The extracellular matrix in hepatocellular carcinoma shows different localization patterns depending on the differentiation and the histological pattern of tumors: immunohistochemical analysis. J Hepatol 21:37–46
Torimura T, Ueno T, Kin M, Inuzuka S, Sugawara H, Tamaki S, Tsuji R, Sujaku K, Sata M, Tanikawa K (1997) Coordinated expression of integrin alpha6beta1 and laminin in hepatocellular carcinoma. Hum Pathol 28:1131–1138
Torimura T, Ueno T, Kin M, Ogata R, Inuzuka S, Sugawara H, Kurotatsu R, Shimada M, Yano H, Kojiro M, Tanikawa K et al (1999) Integrin alpha6beta1 plays a significant role in the attachment of hepatoma cells to laminin. J Hepatol 31:734–740
Torimura T, Ueno T, Kin M, Harad R, Nakamura T, Sakamoto M, Kumashiro R, Yano H et al (2001) Laminin deposition to type IV collagen enhances haptotaxis, chemokinesis, and adhesion of hepatoma cells through beta1-integrins. J Hepatol 35:245–253
Traweger A, Toepfer S, Wagner RN, Zweimueller-Mayer J, Gehwolf R, Lehner C, Tempfer H, Krizbai I, Wilhelm I et al (2013) Beyond cell-cell junctions. Emerging roles of the tight junction scaffold ZO-2. Tissue Barriers 1:e25039
Tsukita S, Katsuno T, Yamazaki Y, Umeda K, Tamura A, Tsukita S (2009) Roles of ZO-1 and ZO-2 in establishment of the belt-like adherens and tight junctions with paracellular permselective barrier function. Ann N Y Acad Sci 1165:44–52
Tu Y, Wu S, Shi X, Chen K, Wu C (2003) Migfilin and Mig-2 link focal adhesions to filamin and the actin cytoskeleton and function in cell shape modulation. Cell 113:37–47
Valastyan S, Weinberg RA (2011) Tumor metastasis: molecular insights and evolving paradigms. Cell 147:275–292
Valdembri D, Caswell PT, Anderson KI, Schwarz JP, König I, Astanina E, Caccavari F, Normal JC, Humphries MJ et al (2009) Neuropilin-1/GIPC1 signaling regulates alpha5beta1 integrin traffic and function in endothelial cells. PLoS Biol 7:e25
Valletta D, Czech B, Spruss T, Ikenberg K, Wild P, Hartmann A, Weiss TS, Oefner PJ, Müller M, Bosserhoff AK et al (2014) regulation and function of the atypical cadherin FAT1 in hepatocellular carcinoma. Carcinogenesis 35:1407–1415
Van Itallie CM, Anderson JM (2013) Claudin interactions in and out of the tight junction. Tissue Barriers 1:e25247
Van Itallie CM, Anderson JM (2014) Architecture of tight junctions and principles of molecular composition. Semin Cell Dev Biol 36:157–165
Varner JA, Cheresh DA (1996) Integrins and cancer. Curr Opin Cell Biol 8:724–730
Volpes R, van den Oord JJ, Desmet VJ (1993) Integrins as differential cell lineage markers of primary liver tumors. Am J Pathol 142:1483–1492
Von Sengbusch A, Gassmann P, Fisch KM, Enns A, Nicolson GL, Haier J (2005) Focal adhesion kinase regulates metastatic adhesion of carcinoma cells within liver sinusoids. Am J Pathol 166:585–596
Wang et al. 2012. http://www.ncbi.nlm.nih.gov/pubmed/22052196
Wiche 1998. http://www.ncbi.nlm.nih.gov/pubmed/9701547
Wickline ED, Du Y, Stolz DB, Kahn M, Monga SP (2013) γ-Catenin at adherens junctions: mechanism and biologic implications in hepatocellular cancer after β-catenin knockdown. Neoplasia 15:421–434
Wozniak et al. 2004. http://www.ncbi.nlm.nih.gov/pubmed/15246682
Wu C (2005) Migfilin and its binding partners: from cell biology to human diseases. J Cell Sci 118:659–664
Wu XZ, Chen D (2006) Cell-matrix talks: effects on differentiation of hepatocellular carcinoma. Minerva Gastroenterol Dietol 52:407–413
Wu Y, Zuo J, Ji G, Saiyin H, Liu X, Yin F, Cao N, Wen Y, Li JJ, Yu L (2009) Proapoptotic function of integrin beta(3) in human hepatocellular carcinoma cells. Clin Cancer Res 15:60–69
Wu X, Chen H, Gao Q, Bai J, Wang X, Zhou J, Qiu S, Xu Y, Shi Y, Wang X, Zhou J et al (2012) Downregulation of JWA promotes tumor invasion and predicts poor prognosis in human hepatocellular carcinoma. Mol Carcinog. doi:10.1002/mc.21981
Xia L, Huang W, Tian D, Chen Z, Zhang L, Li Y, Hu H, Liu J, Chen Z, Tang G, Dou J et al (2014) ACP5, a direct transcriptional target of FoxM1, promotes tumor metastasis and indicates poor prognosis in hepatocellular carcinoma. Oncogene 33:1395–1406
Yam JW, Tse EY, Ng IO (2009) Role and significance of focal adhesion proteins in hepatocellular carcinoma. J Gastroenterol Hepatol 24:520–530
Yamada S, Ichida T, Matsuda Y, Miyazaki Y, Hatano T, Hata K, Asakura H, Hirota N, Geerts A, Wisse E (1992) Tenascin expression in human chronic liver disease and in hepatocellular carcinoma. Liver 12:10–16
Yamasaki H, Krutovskikh V, Mesnil M, Tanaka T, Zaidan-Dagli ML, Omori Y (1999) Role of connexin (gap junction) genes in cell growth control and carcinogenesis. C R Acad Sci Ill 322:151–159
Yano T, Matsui T, Tamura A, Uji M, Tsukita S (2013) The association of microtubules with tight junctions is promoted by cingulin phosphorylation by AMPK. J Cell Biol 203:605–614
Yao M, Zhou XD, Zha XL, Shi DR, Fu J, He JY, Lu HF, Tang ZY (1997) Expression of the integrin alpha5 subunit and its mediated cell adhesion in hepatocellular carcinoma. J Cancer Res Clin Oncol 123:435–440
Yaqoob U, Cao S, Shergill U, Jagavelu K, Geng Z, Yin M, de Assuncao TM, Cao Y, Szabolcs A, Thorgeirsson S, Schwartz M et al (2012) Neuropilin-1 simulates tumor growth by increasing fibril assembly in the tumor microenvironment. Cancer Res 72:4047–4059
Yu X, Zou Y, Li Q, Mao Y, Zhu H, Huang G, Ji G, Luo X, Yu C, Zhang X (2014) Decorin-mediated inhibition of cholangiocarcinoma cell growth and migration and promotion of apoptosis are associated with E-cadherin in vitro. Tumour Biol 35:3103–3112
Yurchenco PD (2011) Basement membranes: cell scaffoldings and signaling platforms. Cold Spring Harb Perspect Biol 3:a004911
Zaidel-Bar R, Itzkovitz S, Ma’ayan A, Iyengar R, Geiger B (2007) Functional atlas of the integrin adhesome. Nat Cell Biol 9:858–867
Zha et al. 2014. http://www.ncbi.nlm.nih.gov/pubmed/24498348
Zhai X, Zhu H, Wang W, Zhang S, Zhang Y, Mao G (2014) Abnormal expression of EMT-related proteins, S100A4, vimentin and E-cadherin, is correlated with clinicopathological features and prognosis in HCC. Med Oncol 31:970
Zhan DQ, Wei S, Liu C, Liang BY, Ji GB, Chen XP, Xiong M, Huang ZY (2012) Reduced N-cadherin expression is associated with metastatic potential and poor surgical outcomes of hepatocellular carcinoma. J Gastroenterol Hepatol 27:173–180
Zhang D, Kaneda M, Nakahama K, Arii S, Morita I (2007) Connexin 43 expression promotes malignancy of HuH7 hepatocellular carcinoma cells via the inhibition of cell-cell communication. Cancer Lett 252:208–215
Zhang KJ, Wang DS, Zhang SY, Jiao XL, Li CW, Wang XS, Yu QC, Cui HN (2010) The E-cadherin repressor slug and progression of human extrahepatic hilar cholangiocarcinoma. J Exp Clin Cancer Res 29:88
Zhang YH, Wang SQ, Sun CR, Wang M, Wang B, Tang JW (2011) Inhibition of JNK1 expression decreases migration and invasion of mouse hepatocellular carcinoma cell line in vitro. Med Oncol 28:966–972
Zhang G, Liu T, Wang Z (2012) Downregulation of MAGI1 associates with poor prognosis of hepatocellular carcinoma. J Invest Surg 25:93–99
Zhao J, Guan JL (2009) Signal transduction by focal adhesion kinase in cancer. Cancer Metastasis Rev 28:35–49
Zhao M, Laissue JA, Zimmermann A (1996) Tenascin and type IV collagen expression in liver cell dysplasia and in hepatocellular carcinoma. Histol Histopathol 11:323–333
Zheng S, Ruan Y, Wu Z, Tang J (1997) The relationship between 67KD laminin receptor expression and metastasis of hepatocellular carcinoma. J Tongji Med Univ 17:200–202
Zheng J, Li Y, Yang J, Liu Q, Shi M, Zhang R, Shi H, Ren Q, Ma J, Guo H, Tao Y et al (2011) NDRG2 inhibits hepatocellular carcinoma adhesion, migration and invasion by regulating CD24 expression. BMC Cancer 11(251):1–9
Zhou ZJ, Dai Z, Zhou SL, Fu XT, Zhao YM, Shi YH, Zhou J, Fan J (2013) Overexpression of HnRNP A1 promotes tumor invasion through regulating CD44v6 and indicates poor prognosis for hepatocellular carcinoma. Int J Cancer 132:1080–1089
Zhu P, Lv J, Yang Z, Guo L, Zhang L, Li M, Han W, Chen X, Zhuang H, Lu F (2014) Protocadherin 9 inhibits epithelial-mesenchymal transition and cell migration through activating GSK-3β in hepatocellular carcinoma. Biochem Biophys Res Commun 452:567–574
Ziober BL, Lin CS, Kramer RH (1996) Laminin-binding integrins in tumor progression and metastasis. Semin Cancer Biol 7:119–128
Zohar R, Suzuki N, Suzuki K, Arora P, Glogauer M, McCulloch CA, Sodek J (2000) Intracellular osteopontin is an integral component of the CD44-ERM complex involved in cell migration. J Cell Physiol 184:118–130
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Copyright information
© 2017 Springer International Publishing Switzerland
About this entry
Cite this entry
Zimmermann, A. (2017). Mechanisms of Invasion and Metastasis: General Aspects and the Role of Cell Junctions, Adhesion, and Extracellular Matrix. In: Tumors and Tumor-Like Lesions of the Hepatobiliary Tract. Springer, Cham. https://doi.org/10.1007/978-3-319-26956-6_180
Download citation
DOI: https://doi.org/10.1007/978-3-319-26956-6_180
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-26954-2
Online ISBN: 978-3-319-26956-6
eBook Packages: MedicineReference Module Medicine